Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism
dadun.citation.endingPage | 1645 | es_ES |
dadun.citation.number | 9 | es_ES |
dadun.citation.publicationName | Cell Metabolism | es_ES |
dadun.citation.startingPage | 1630 | es_ES |
dadun.citation.volume | 35 | es_ES |
dc.contributor.author | Tovar, S. (Sulay) | |
dc.contributor.author | Nogueiras, R. (Rubén) | |
dc.contributor.author | Díaz-Quintana, A. (Antonio) | |
dc.contributor.author | Pérez-Mejias, G. (Gonzalo) | |
dc.contributor.author | Bravo, S. (Susana B.) | |
dc.contributor.author | Fernández, U. (Uxía) | |
dc.contributor.author | Gonzalez-Rellan, M.J. (María J.) | |
dc.contributor.author | Fondevila, M.F. (Marcos F.) | |
dc.contributor.author | Coppari, R. (Roberto) | |
dc.contributor.author | Veyrat-Durebex, C. (Christelle) | |
dc.contributor.author | Parracho, T. (Tamara) | |
dc.contributor.author | Woodhoo, A. (Ashwin) | |
dc.contributor.author | Frühbeck, G. (Gema) | |
dc.contributor.author | Novoa, E. (Eva) | |
dc.contributor.author | Prevot, V. (Vincent) | |
dc.contributor.author | da-Silva-Lima, N. (Natalia) | |
dc.contributor.author | Dieguez, C. (Carlos) | |
dc.contributor.author | Delgado, T.C. (Teresa C.) | |
dc.contributor.author | Rodriguez, A. (Amaia) | |
dc.contributor.author | Guallar, D. (Diana) | |
dc.contributor.author | Schwaninger, M. (Markus) | |
dc.contributor.author | López, M. (Miguel) | |
dc.contributor.author | Ramos, L. (Lucía) | |
dc.contributor.author | Chantada-Vazquez, P. (Pilar) | |
dc.contributor.author | Díaz-Moreno, I. (Irene) | |
dc.contributor.author | Martinez-Chantar, M.L. (María Luz) | |
dc.contributor.author | Riobello, C | |
dc.contributor.author | Serrano-Macia, M. (Marina) | |
dc.date.accessioned | 2023-12-19T10:08:02Z | |
dc.date.available | 2023-12-19T10:08:02Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Neddylation is a post-translational mechanism that adds a ubiquitin-like protein, namely neural precursor cell expressed developmentally downregulated protein 8 (NEDD8). Here, we show that neddylation in mouse liver is modulated by nutrient availability. Inhibition of neddylation in mouse liver reduces gluconeogenic capacity and the hyperglycemic actions of counter-regulatory hormones. Furthermore, people with type 2 diabetes display elevated hepatic neddylation levels. Mechanistically, fasting or caloric restriction of mice leads to neddylation of phosphoenolpyruvate carboxykinase 1 (PCK1) at three lysine residues—K278, K342, and K387. We find that mutating the three PCK1 lysines that are neddylated reduces their gluconeogenic activity rate. Molecular dynamics simulations show that neddylation of PCK1 could re-position two loops surrounding the catalytic center into an open configuration, rendering the catalytic center more accessible. Our study reveals that neddylation of PCK1 provides a finely tuned mechanism of controlling glucose metabolism by linking whole nutrient availability to metabolic homeostasis. | es_ES |
dc.description.note | This is an open access article under the CC BY-NC-ND license | es_ES |
dc.description.sponsorship | This work was supported by grants from: FEDER/Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación (M.L.M.-C.: PID2020-117116RB-I00; C.D.: BFU2017-87721; M.L.: RTI2018-101840-BI00; R.N.: PID2021-126096NB-I00 and RED2018-102379-T); Xunta de Galicia (R.N.: 2021-CP085 and 2020-PG0157); Fundacio´ n BBVA (to R.N.); Subprograma Retos Colaboracio´ n RTC2019-007125-1 (to M.L.M.-C.); Proyectos Investigación en Salud DTS20/00138 (to M.L.M.-C.); Proyectos Investigación en Salud (M.L.M.-C.: DTS20/00138); Fundación Atresmedia (to M.L. and R.N.); and Fundación La Caixa (to M.L., M.L.M.-C., and R.N.). This research also received funding from the European Community’s H2020 Framework Programme (ERC Synergy Grant-2019-WATCH- 810331, to R.N., V.P., and M.S.).The Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología de la Obesidad y Nutrición (CIBERobn) and the Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Hepáticas y Digestivas (CIBERehd) are initiatives of the Instituto de Salud Carlos III (ISCIII) of Spain, which is supported by FEDER funds. We thank MINECO for the Severo Ochoa Excellence Accreditation bioGUNE (SEV-2016-0644) to CIC. | es_ES |
dc.identifier.citation | Gonzalez-Rellan, M.J. (María J.); Fernández, U. (Uxía); Parracho, T. (Tamara); et al. "Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism". Cell Metabolism. 35 (9), 2023, 1630 - 1645 | es_ES |
dc.identifier.doi | 10.1016/j.cmet.2023.07.003 | |
dc.identifier.issn | 1932-7420 | |
dc.identifier.pmid | 37541251 | |
dc.identifier.uri | https://hdl.handle.net/10171/68096 | |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation | info:eu-repo/grantAgreement/AEI/Proyectos I+D/PID2020-117116RB-I00/[ES]/DESVELANDO EL PAPEL DE LA NEDILACION EN EL ESTRES NUTRICIONAL | es_ES |
dc.relation.center | Clínica Universidad de Navarra | |
dc.relation.department | Endocrinología y Nutrición | |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | PCK1 | es_ES |
dc.subject | Calorie restriction | es_ES |
dc.subject | Fasting | es_ES |
dc.subject | Glucagon | es_ES |
dc.subject | Glucose metabolism | es_ES |
dc.subject | Neddylation | es_ES |
dc.subject | Type 2 diabetes | es_ES |
dc.title | Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dspace.entity.type | Publication | es |
relation.isAuthorOfPublication | 5716a149-8ad6-45d3-b30b-4f67d30cd2fb | |
relation.isAuthorOfPublication | d6d4c851-6ed5-47d3-9361-c80bbfae88e6 | |
relation.isAuthorOfPublication | 4b8e5faf-b722-42a5-8a8e-eaa7551b103a | |
relation.isAuthorOfPublication | 5582dfa0-993a-467f-a097-df37fc0c578d | |
relation.isAuthorOfPublication | e01e519b-f836-4fcb-86d7-31112734e8e2 | |
relation.isAuthorOfPublication | b5339a5a-3803-4411-b618-ee1c94654657 | |
relation.isAuthorOfPublication | eb5f3b93-72d6-4030-b4f0-feb2293ebe75 | |
relation.isAuthorOfPublication | 42515fd5-cb1f-44a3-99aa-b643d79de50b | |
relation.isAuthorOfPublication | 0aab48ad-95e3-4a9b-aead-c2edc24d5433 | |
relation.isAuthorOfPublication | 9d98726e-c438-4ce5-8934-f502d9067ba2 | |
relation.isAuthorOfPublication | f34ebaee-7f32-4a0a-9a1b-538e674573f7 | |
relation.isAuthorOfPublication | a9e90cb2-bac1-43fb-a0b2-5e3409f9c860 | |
relation.isAuthorOfPublication | 7f0b1f72-bc91-4ab0-a3fd-21e9a3fb663b | |
relation.isAuthorOfPublication | 766fd1b8-02a2-455c-9709-c565201be738 | |
relation.isAuthorOfPublication | 0dd0ae31-acd4-4768-b1d7-c3ddd654d79f | |
relation.isAuthorOfPublication | 9e088f99-dea7-42cf-8026-21c1027c1af8 | |
relation.isAuthorOfPublication | 54b49b82-82ec-4bb6-9d48-c54fb1d572fb | |
relation.isAuthorOfPublication | 3eca531a-fb4a-4068-bb67-7c9ca55c8fb0 | |
relation.isAuthorOfPublication | 50976a5f-9842-47f1-8a9c-508e59996427 | |
relation.isAuthorOfPublication | 1dc9d5a7-af90-4a94-86a4-9e3e6b3d4058 | |
relation.isAuthorOfPublication | cfedba68-3192-4bac-813e-ca188cac05b6 | |
relation.isAuthorOfPublication | 12ffac18-b941-4137-95fa-66b0e634053e | |
relation.isAuthorOfPublication | 93cf658b-f13f-44be-a743-a642ea316838 | |
relation.isAuthorOfPublication | 15ebaac2-b075-47bb-bc62-f7ad9fa0c222 | |
relation.isAuthorOfPublication | a7c48370-d946-48d4-ac0f-5069f5ed0b8a | |
relation.isAuthorOfPublication | df06120b-2a53-4074-a155-638f899b2ce5 | |
relation.isAuthorOfPublication | a63b04b6-403d-4cad-97ff-102226d374c5 | |
relation.isAuthorOfPublication | 701bbee2-a548-41c8-98b5-30f1c8b94dc5 | |
relation.isAuthorOfPublication.latestForDiscovery | 5716a149-8ad6-45d3-b30b-4f67d30cd2fb |